FDA approves Imdelltra for patients with extensive-stage small cell lung cancer
The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer.
F.D.A. Approves Drug for Persistently Deadly Form of Lung Cancer
The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.
US FDA approves Amgen drug for small cell lung cancer
The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for treating adults with advanced small cell lung cancer that has worsened despite chemotherapy.
FDA approves Amgen's treatment for most deadly form of lung cancer
The Food and Drug Administration on Thursday approved Amgen's treatment for patients with the most deadly form of lung cancer.  The agency cleared the drug, called Imdelltra, as a second or later-line treatment for adults with advanced small-cell lung cancer.
Pharmalittle: We’re reading about an Amgen drug for lung cancer, a Novo plant fire, and more
The FDA approved an innovative treatment from Amgen for patients with small cell lung cancer who have exhausted all other options.
FDA Approves Tarlatamab for Extensive-Stage Small Cell Lung Cancer
Continued approval of the first-in-class bispecific T-cell engager (BiTE) may depend on proof of clinical benefit.
FDA Approves New Drug for Deadly Lung Cancer
"The FDA's approval of Imdelltra marks a pivotal moment for patients battling [extensive-stage small cell lung cancer]," Dr. Jay Bradner, executive vice president of research and
Immunotherapy may boost survival after lung cancer surgery
Immunotherapy can boost the survival of early-stage lung cancer patients eligible for surgery when it's combined with ...
phillyvoice.com1d
Lung cancer is the deadliest of all cancers, and screening could save many lives − if more people could access it
Many are unaware that they qualify, or have misconceptions about what to expect. Stigmas about smoking also are a barrier.
FiercePharma1d
Amgen's 'watershed' lung cancer drug nabs FDA nod in deadly, tough-to-treat form of the disease
Seven months after Amgen’s chief medical officer referred to trial results for the company's investigational lung cancer ...
Lung cancer mystery: Why are healthy, non-smoking, Asian women contracting the disease?
A Bay Area-based study finds that 80% of Asian American women with lung cancer never smoked and researchers are trying to ...
Pharmabiz8h
Amgen’s Imdelltra receives US FDA approval to treat adult patients with extensive-stage small cell lung cancer
Amgen announced that the US Food and Drug Administration (FDA) has approved Imdelltra (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) with ...
Science Daily1d
Lung Cancer News
the most common type of lung cancer. These findings open the ... Genetic Signature May Predict Response to Immunotherapy for Non-Small Cell Lung Cancer Feb. 23, 2024 — A new study identified a ...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's ...
Cure Today1d
Blood Sugar Levels May Affect Cancer Outcomes in Patients With Diabetes
When it comes to high blood sugar, cancer and diabetes can create a “vicious cycle,” as one expert explained. An ...